Point72 Asset Management »

Summit Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $15M 801k 18.96

More positions owned by Point72 Asset Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Arista Networks Com Shs (ANET)
Asml Hldg Nv N Y Registry Shs (ASML)
Broadcom (AVGO)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Teradyne (TER)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Applied Materials (AMAT)
Spotify Technology S A SHS (SPOT)
Equinix (EQIX)
Home Depot (HD)

View all positions for Point72 Asset Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
BlackRock
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
UBS Group
Geode Capital Management
Susquehanna International
D. E. Shaw & Co
Morgan Stanley
Pictet Asset Management Holding SA
Apeiron Capital
Citadel Advisors
Two Sigma Investments

View all funds holding Summit Therapeutics